Literature DB >> 6479108

Subcellular distribution of neuroactive amino acids in brains of genetically epileptic rats.

D W Bonhaus, S E Lippincott, R J Huxtable.   

Abstract

The subcellular distribution of amino acids was compared in brains of genetically seizure-susceptible (SS) and genetically seizure-resistant (SR) rats. The total taurine content (mumol/brain) in the P2B, or synaptosomal, fraction in SS rats was only 37% of that of SR rats. Glutamate, glutamine, glycine, alanine, and gamma-aminobutyric acid (GABA) contents were unaltered. No alterations in total content were found in other subcellular fractions for the amino acids studied. SS animals that had never been stimulated to audiogenic seizure had decreased concentrations of taurine (nmol/mg protein) in the P2, P2B, and P2C fractions as compared with SR animals. These fractions contain crude synaptosomes, enriched synaptosomes, and enriched mitochondria, respectively. Phosphoethanolamine concentrations were also decreased in the P2B fractions, but concentrations of other amino acids were unaltered, as compared with SR animals. Twenty-four hours after the intracerebroventricular injection of taurine (6 mumol) in SS animals that had never been convulsed, taurine concentrations were significantly increased in whole brain homogenate and P2 and P2B fractions as compared with SS animals not given taurine. This treatment left unaltered the concentrations of glutamate, glutamine, GABA, and glycine in brain homogenate and P2 fraction. Because decreases in taurine concentration were seen in animals that had not been convulsed, these alterations are intrinsic to the SS strain and are not a consequence of convulsive activity. In view of the antiepileptic action of taurine, and the fact that an impairment of taurine transport in the brain of SS rats had previously been demonstrated, we suggest that a defect in the biochemistry of taurine is partially responsible for the seizure susceptibility of the SS rat.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6479108     DOI: 10.1111/j.1528-1157.1984.tb03462.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

Review 1.  Anticonvulsant drug action and regional neurotransmitter amino acid changes.

Authors:  A G Chapman; G P Hart
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Phosphoethanolamine transiently enhances excitability of rat hippocampal neurons in vitro.

Authors:  M Zeise; A Lehmann
Journal:  J Comp Physiol A       Date:  1987-08       Impact factor: 1.836

3.  Disturbances of amino acids from temporal lobe synaptosomes in human complex partial epilepsy.

Authors:  D M Labiner; C C Yan; M E Weinand; R J Huxtable
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

4.  Involvement of synaptosomal neurotransmitter amino acids in audiogenic seizure-susceptibility and -severity of Rb mice.

Authors:  S Simler; L Ciesielski; J Clement; A Rastegar; P Mandel
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

5.  Amino acid content in astroglial primary cultures from different brain regions during cultivation.

Authors:  A Lehmann; E Hansson
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

6.  Alterations in synaptosomal neurotransmitter amino acids in "petit-mal" rats at a daytime and a nighttime.

Authors:  S Simler; L Ciesielski; S Gobaille; P Mandel
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

7.  Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus.

Authors:  Germán Sierra-Paredes; Ana I Loureiro; Lyndon C Wright; Germán Sierra-Marcuño; Patrício Soares-da-Silva
Journal:  BMC Neurosci       Date:  2014-12-20       Impact factor: 3.288

Review 8.  Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes.

Authors:  Zeinab Rafiee; Alba M García-Serrano; João M N Duarte
Journal:  Nutrients       Date:  2022-03-18       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.